Download this article for considerations of six shortcomings in vaccine development as it relates to intradermal delivery and thoughts on the industry can address these gaps:
- Where vaccines are delivered in the body
- Practical difficulties with intradermal delivery
- Delivery volume
- Scale-up
- Cold chain requirements
- Non-representative clinical trials
Get Your Copy NowGet Your Copy Now
Fields marked with a * are required.
Related resources
Explore our other resources to discover valuable insights on the latest trends in drug delivery.
Live-Attenuated VEEV vaccine delivered by iDNA using microneedles is immunogenic in rabbits
Learn More
Kindeva drug delivery – microneedles
Learn More
Kindeva Drug Delivery world vaccine congress presentation
Learn MoreLet’s transform tomorrow together
Every patient deserves a brighter tomorrow. As your strategic partner, we are dedicated to building your lasting legacy and helping you fast-track healthier tomorrows. You dream it, we deliver it.